Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours
Jill E. Kucab(King's College London), Sandra E. Dunn(Muscular Dystrophy UK)
Cited by 93
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
|Cancer Research|2008|407
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
|The Lancet Oncology|2013|404